C-Rad AB Class B (DE:24C)
FRANKFURT:24C
Want to see DE:24C full AI Analyst Report?
24C Stock Chart & Stats
€2.83
€0.01(0.40%)
At close: 4:00 PM EST
€2.83
€0.01(0.40%)
Day’s Range― - ―
52-Week Range€2.18 - €3.31
Previous CloseN/A
Volume0.00
Average Volume (3M)162.00
Market Cap
€106.50M
Enterprise Value€975.87M
Total Cash (Recent Filing)€135.20M
Total Debt (Recent Filing)€9.40M
Price to Earnings (P/E)19.5
Beta0.33
Next Earnings
Jul 17, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.88
Shares Outstanding32,904,050
10 Day Avg. Volume200
30 Day Avg. Volume162
Financial Highlights & Ratios
PEG Ratio-1.27
Price to Book (P/B)3.12
Price to Sales (P/S)2.45
P/FCF Ratio21.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.13
Revenue Forecast (FY)€41.82M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage (debt-to-equity ~0.05) gives C‑Rad financial flexibility and resilience. This reduces refinancing risk and preserves capacity to fund R&D, service expansions or absorb short-term demand swings, supporting stability over the next 2–6 months.
Solid Operating ProfitabilityOperating profitability (EBIT ~10.7%, EBITDA ~12.5%) indicates healthy unit economics in SGRT and positioning systems. Sustained operating margins provide internal funding for product development and help the business withstand cyclical equipment sales softness.
Recurring After-sales RevenueRevenue from service agreements, maintenance and upgrades creates annuity-like cash flows tied to the installed base. That recurring mix stabilizes revenue and margin profiles, smooths seasonality, and supports predictable cash generation over the medium term.
Bears Say
Declining Revenue TrendTrailing revenue contraction (-3.19% TTM and reported RevenueGrowth weakening) signals softening demand or lost share. Continued top-line decline erodes operating leverage, constrains reinvestment capacity and can pressure margins and growth initiatives over a 2–6 month horizon.
Weak And Volatile Cash GenerationA roughly -74% drop in TTM free cash flow and operating cash flow about half of net income indicate fragile cash conversion. Volatile cash limits ability to self-fund capex or acquisitions, increases reliance on external financing, and raises execution risk.
Compressed Net Margins And Low ROENet margin compressed to ~2.35% with ROE near 3.0%, showing weak bottom-line conversion despite decent operating margins. Persistent below-the-line costs or inefficiencies reduce shareholder returns and limit the firm's ability to accumulate capital for strategic investments.
C-Rad AB Class B News
24C FAQ
What was C-Rad AB Class B’s price range in the past 12 months?
C-Rad AB Class B lowest stock price was €2.18 and its highest was €3.31 in the past 12 months.
What is C-Rad AB Class B’s market cap?
C-Rad AB Class B’s market cap is €106.50M.
When is C-Rad AB Class B’s upcoming earnings report date?
C-Rad AB Class B’s upcoming earnings report date is Jul 17, 2026 which is in 53 days.
How were C-Rad AB Class B’s earnings last quarter?
C-Rad AB Class B released its earnings results on May 06, 2026. The company reported €0.03 earnings per share for the quarter, beating the consensus estimate of €0.014 by €0.016.
Is C-Rad AB Class B overvalued?
According to Wall Street analysts C-Rad AB Class B’s price is currently Overvalued.
Does C-Rad AB Class B pay dividends?
C-Rad AB Class B does not currently pay dividends.
What is C-Rad AB Class B’s EPS estimate?
C-Rad AB Class B’s EPS estimate is 0.03.
How many shares outstanding does C-Rad AB Class B have?
C-Rad AB Class B has 32,904,050 shares outstanding.
What happened to C-Rad AB Class B’s price movement after its last earnings report?
C-Rad AB Class B reported an EPS of €0.03 in its last earnings report, beating expectations of €0.014. Following the earnings report the stock price went up 32.471%.
Which hedge fund is a major shareholder of C-Rad AB Class B?
Currently, no hedge funds are holding shares in DE:24C
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
C-Rad AB Class B
C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Technical Analysis
Paxman AB
―
Senzime AB
―
Bactiguard Holding AB
―
Integrum AB Class B
―
Sedana Medical AB
―